These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 1738116

  • 1. Identification of multiple muscarinic binding site subtypes in cat and human cerebral vasculature.
    Dauphin F, Hamel E.
    J Pharmacol Exp Ther; 1992 Feb; 260(2):660-7. PubMed ID: 1738116
    [Abstract] [Full Text] [Related]

  • 2. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.
    Norman AB, Eubanks JH, Creese I.
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1116-22. PubMed ID: 2703964
    [Abstract] [Full Text] [Related]

  • 3. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
    Flynn DD, Mash DC.
    Synapse; 1993 Aug; 14(4):283-96. PubMed ID: 8248852
    [Abstract] [Full Text] [Related]

  • 4. M1 and M3 muscarinic receptor subtypes in rat forebrain.
    Pavia J, Marquez E, Laukkonen S, Martos F, Gómez A, Sánchez de la Cuesta F.
    Methods Find Exp Clin Pharmacol; 1991 Dec; 13(10):653-60. PubMed ID: 1770828
    [Abstract] [Full Text] [Related]

  • 5. Selectivity of class I antiarrhythmic agents, disopyramide, pirmenol, and pentisomide for peripheral muscarinic M2 and M3 receptors.
    Endou M, Hattori Y, Gando S, Kanno M.
    J Cardiovasc Pharmacol; 1992 May; 19(5):674-81. PubMed ID: 1381764
    [Abstract] [Full Text] [Related]

  • 6. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.
    Jakubík J, Bacáková L, el-Fakahany EE, Tucek S.
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1077-83. PubMed ID: 7562472
    [Abstract] [Full Text] [Related]

  • 7. Interactions of cocaine with primary and secondary recognition sites on muscarinic receptors.
    Flynn DD, Vaishnav AA, Mash DC.
    Mol Pharmacol; 1992 Apr; 41(4):736-42. PubMed ID: 1569924
    [Abstract] [Full Text] [Related]

  • 8. Characterization of [3H]Ba 679 BR, a slowly dissociating muscarinic antagonist, in human lung: radioligand binding and autoradiographic mapping.
    Haddad EB, Mak JC, Barnes PJ.
    Mol Pharmacol; 1994 May; 45(5):899-907. PubMed ID: 8190106
    [Abstract] [Full Text] [Related]

  • 9. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE.
    Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
    [Abstract] [Full Text] [Related]

  • 10. Interaction of neuromuscular blocking drugs with recombinant human m1-m5 muscarinic receptors expressed in Chinese hamster ovary cells.
    Cembala TM, Sherwin JD, Tidmarsh MD, Appadu BL, Lambert DG.
    Br J Pharmacol; 1998 Nov; 125(5):1088-94. PubMed ID: 9846649
    [Abstract] [Full Text] [Related]

  • 11. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M, Waelbroeck M, Christophe J.
    Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
    [Abstract] [Full Text] [Related]

  • 12. Recognition of muscarinic cholinergic receptors in human SK-N-SH neuroblastoma cells by quaternary and tertiary ligands is dependent upon temperature, cell integrity, and the presence of agonists.
    Fisher SK.
    Mol Pharmacol; 1988 Apr; 33(4):414-22. PubMed ID: 3357485
    [Abstract] [Full Text] [Related]

  • 13. Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.
    Tucek S, Musílková J, Nedoma J, Proska J, Shelkovnikov S, Vorlícek J.
    Mol Pharmacol; 1990 Nov; 38(5):674-80. PubMed ID: 2233700
    [Abstract] [Full Text] [Related]

  • 14. Selective labeling and localization of the M4 (m4) muscarinic receptor subtype.
    Ferrari-Dileo G, Waelbroeck M, Mash DC, Flynn DD.
    Mol Pharmacol; 1994 Dec; 46(6):1028-35. PubMed ID: 7808421
    [Abstract] [Full Text] [Related]

  • 15. Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions.
    Lee NH, el-Fakahany EE.
    J Pharmacol Exp Ther; 1988 Sep; 246(3):829-38. PubMed ID: 3418516
    [Abstract] [Full Text] [Related]

  • 16. Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells.
    Lazareno S, Buckley NJ, Roberts FF.
    Mol Pharmacol; 1990 Dec; 38(6):805-15. PubMed ID: 2250662
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological characterization of muscarinic acetylcholine binding sites in human and bovine cerebral microvessels.
    Linville DG, Hamel E.
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug; 352(2):179-86. PubMed ID: 7477441
    [Abstract] [Full Text] [Related]

  • 18. Heterogeneity of muscarinic receptor subtypes in cerebral blood vessels.
    Garcia-Villalon AL, Krause DN, Ehlert FJ, Duckles SP.
    J Pharmacol Exp Ther; 1991 Jul 01; 258(1):304-10. PubMed ID: 1649298
    [Abstract] [Full Text] [Related]

  • 19. Characterization of muscarinic receptors in the human bladder mucosa: direct quantification of subtypes using 4-DAMP mustard.
    Yoshida A, Seki M, Nasrin S, Otsuka A, Ozono S, Takeda M, Masuyama K, Araki I, Ehlert FJ, Yamada S.
    Urology; 2011 Sep 01; 78(3):721.e7-721.e12. PubMed ID: 21777958
    [Abstract] [Full Text] [Related]

  • 20. Characterization of 3H-N-methylscopolamine binding to intact rat thymocytes.
    Rinner I, Porta S, Schauenstein K.
    Endocrinol Exp; 1990 Mar 01; 24(1-2):125-32. PubMed ID: 2361455
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.